Organization
Moffitt Cancer Center and Research Institute
8 abstracts
Abstract
Phase 1B study of avelumab and whole brain radiotherapy (WBRT) in patients with leptomeningeal disease (LMD) from epithelial carcinomas: Final results and molecular analyses with single cell RNA sequencing.Org: Moffitt Cancer Center, H. Lee Moffitt Cancer Center and Research Institute, Moffitt Cancer Center and Research Institute, National Cancer Institute, Vilnius, Lithuania,
Abstract
Association between genomic alterations and response of triple-negative breast cancers (TNBC) to talimogene laherparepvec (TVEC) in combination with neoadjuvant chemotherapy (NACT).Org: H. Lee Moffitt Cancer Center and Research Institute, Moffitt Cancer Center and Research Institute, Moffitt Cancer Center,
Abstract
Toxicity reporting consistency and subjective minimizing language use in colorectal cancer (CRC) and pancreatic cancer (PaC) clinical trials: A systematic review of phase III randomized controlled trials (RCTs) presented at ASCO between 2012-2022.Org: H. Lee Moffitt Cancer Center and Research Institute, Moffitt Cancer Center and Research Institute, London Health Sciences Centre & Schulich School of Medicine, University of Toronto, Queen's University, Belfast,
Abstract
Association of neutrophil-lymphocyte ratio (NLR) with clinical outcomes in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with combination of cetuximab and nivolumab (C+N).Org: Moffitt Cancer Center, The Ohio State University - James Cancer Hospital and Solove Research Institute, Emory University School of Medicine, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morsani College of Medicine,
Abstract
ACTION-1 phase Ib/3 trial of RYZ101 in somatostatin receptor subtype 2–expressing (SSTR2+) gastroenteropancreatic neuroendocrine tumors (GEP-NET) progressing after 177Lu somatostatin analogue (SSA) therapy: Initial safety analysis.Org: Advanced Molecular Imaging and Therapy, Hoag Family Cancer Institute and University of Southern California, MD Anderson Cancer Center, Moffitt Cancer Center and Research Institute, Nebraska Cancer Specialists,
Abstract
A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases: SWOG S2000.Org: Moffitt Cancer Center and Research Institute, Southwest Oncology Group Statistical Center, UPMC Hillman Cancer Center, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, Columbia University Irving Medical Center, New York, NY, USA,
Abstract
Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum: Outcomes for patients with melanoma.Org: H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, Jordan University of Science and Technology, Irbid, Jordan, UPMC Health Plan,
Abstract
Outcomes of pancreatic malignancy in octogenarians: A single tertiary center experience.Org: Moffitt Cancer Center and Research Institute, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Oncology Unit S. Chiara Hospital, Trento, Italy,